Skip to main content
. Author manuscript; available in PMC: 2024 Feb 1.
Published in final edited form as: Clin Gastroenterol Hepatol. 2022 Jul 20;21(2):520–531.e10. doi: 10.1016/j.cgh.2022.07.012

TABLE 4.

Regression analysis on preferring a FIT every year over colonoscopy every 10 years for CRC screening; screening test preferences were determined through simulations from conjoint analysis-derived data.

Variable Prefers a FIT every year for CRC screening
40-49 year old (n=456) ≥50 year old (n=543)
Sex:
   Male reference reference
   Female 1.24 [0.72, 2.11] 1.59 [0.90, 2.81]
Race/ethnicity:
   Non-Hispanic White reference reference
   Non-Hispanic Black 0.68 [0.26, 1.80] 1.00 [0.36, 2.79]
   Hispanic 0.80 [0.32, 2.01] 1.13 [0.31, 4.13]
   Non-Hispanic Asian 1.44 [0.41, 5.05] 0.82 [0.20, 3.35]
   Other 1.20 [0.28, 5.17] 0.85 [0.17, 4.20]
Educational attainment:
   High school degree or less reference reference
   Some college education 1.15 [0.57, 2.33] 0.85 [0.39, 1.83]
   College degree 0.68 [0.35, 1.34] 0.85 [0.41, 1.78]
   Graduate degree 0.74 [0.31, 1.79] 0.84 [0.32, 2.24]
Marital status:
   Married or living with a partner reference reference
   Not married 0.98 [0.57, 1.70] 1.29 [0.72, 2.30]
Total household income, $:
   <50,000 reference Reference
   50,000–100,000 1.54 [0.80, 2.97] 0.93 [0.48, 1.79]
   ≥100,001 0.77 [0.35, 1.69] 0.70 [0.29, 1.71]
   Prefer not to say 1.86 [0.27, 12.69] 1.09 [0.15, 7.69]
Employment status:
   Unemployed, on disability, on leave from work, retired, or homemaker reference reference
   Employed or student 0.99 [0.56, 1.76] 1.25 [0.69, 2.28]
Has health insurance 1.37 [0.67, 2.77] 0.63 [0.24, 1.69]
Has usual source of care 0.78 [0.39, 1.55] 0.93 [0.43, 2.04]
Self-reported health status:
   Excellent reference reference
   Very good 0.90 [0.34, 2.37] 0.80 [0.28, 2.27]
   Good 1.18 [0.45, 3.06] 0.98 [0.34, 2.82]
   Fair/Poor 1.46 [0.50, 4.21] 0.86 [0.26, 2.80]
Number of medical comorbidities a:
   0 reference reference
   1 0.50 [0.23, 1.07] 2.19 [0.94, 5.09]
   ≥2 0.37 [0.18, 0.76] 1.91 [0.92, 3.97]
Number of GI comorbidities b:
   0 reference reference
   1 0.67 [0.33, 1.38] 1.58 [0.74, 3.37]
   ≥2 0.87 [0.35, 2.22] 1.41 [0.45, 4.45]
Number of GI symptoms experienced in past 3 months c:
   0 reference reference
   1 1.10 [0.57, 2.11] 0.73 [0.36, 1.49]
   ≥2 1.10 [0.61, 1.99] 0.82 [0.40, 1.70]
US region:
   Northeast reference reference
   South 1.24 [0.61, 2.55] 1.40 [0.67, 2.92]
   Midwest 0.99 [0.45, 2.18] 0.88 [0.41, 1.87]
   West 1.19 [0.53, 2.65] 1.08 [0.50, 2.33]
Plans to get screened for CRC 0.75 [0.42, 1.34] 0.31 [0.16, 0.58]
Has non-first degree relative or friend diagnosed with CRC 0.94 [0.48, 1.83] 0.87 [0.40, 1.91]
Self-perceived CRC susceptibility (1-5 scale; higher=more susceptible) 0.74 [0.53, 1.04] 0.79 [0.55, 1.13]
Self-perceived impact of CRC diagnosis (1-5 scale; higher=more severe impact) 0.97 [0.61, 1.54] 0.82 [0.53, 1.26]
Self-perceived benefits of CRC screening (1-5 scale; higher=more beneficial) 1.03 [0.66, 1.60] 0.72 [0.42, 1.24]
Self-perceived barriers to CRC screening (1-5 scale; higher=more barriers) 1.25 [0.83, 1.89] 1.32 [0.82, 2.14]

Data are presented as aOR [95% CI]. All the variables in the table were included in the multivariable logistic regression model; sex–prefer not to say (n=1) was not included in the regression model as it perfectly predicted the outcome. aOR, adjusted odds ratio; CI, confidence interval; CRC, colorectal cancer; GI, gastrointestinal.

a

Includes anemia or other blood disease, back pain, cancer, depression, diabetes, heart disease, high blood pressure, kidney disease, lung disease, migraines, osteoarthritis or degenerative arthritis, rheumatoid arthritis, or other medical problems.

b

Includes celiac disease, cirrhosis, diverticulitis, gallstones, gastroenteritis, gastroesophageal reflux disease, gastroparesis, irritable bowel syndrome, liver disease, pancreatitis, or ulcer or stomach disease.

c

Includes abdominal pain or discomfort, anal or rectal pain, bloating, bowel incontinence, constipation, diarrhea, dysphagia, heartburn, nausea/vomiting, or regurgitation.